RLMD
RLMD
NASDAQ · Pharmaceuticals

Relmada Therapeutics Inc

$3.80
+0.03 (+0.80%)
As of Nov 7, 2:15 AM ET ·
Next Earnings Report
Nov 12, 2026
After Market Close
4 days away
EPS Estimate $-0.15
EPS Surprise History
Earnings Summary
Beats (Last 2) 0/2
Avg Surprise -56.8%
Latest EPS $-0.22
History 2 quarters
Earnings History
Date Quarter EPS Est EPS Actual Surprise Surprise % Result
Aug 6, 2026 Q3 FY2026 $-0.20 — — — —
May 12, 2026 Q2 FY2026 $-0.20 $-0.22 -$0.02 -10.6% Miss
Mar 19, 2026 Q1 FY2026 $-0.14 $-0.29 -$0.15 -103.1% Miss